Main Menu
Print PDF

Capital Markets Update and Overview - Deal-Making and Exit Strategies Prevailing in the Life Sciences Sector

Finance and Accounting for Bioscience Companies (Boston, MA) | September 25, 2018

Ryan Udell, Co-Chair of the Corporate and Securities Group, and John Eagan, Partner in the Tax and Estates Group will present at CBI's Finance and Accounting for Bioscience Companies Conference. Their presentation, "Capital Markets Update and Overview - Deal-Making and Exit Strategies Prevailing in the Life Sciences Sector," will cover term sheets, tax reform and its impact on pharmaceutical deals, and strategies for maximizing value through the negotiation stage.  

The two-day conference convenes life sciences professionals from small and mid-sized bio-tech and pharmaceutical companies. Strategies on how to develop lean and efficient finance team as well as approaches to implement scalable financial reporting processes will be presented over the course of two days. The conference also covers the challenges faced when transitioning from private to public and when entering into collaborations and recognizing revenue.

Back to Page